View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Kemwell
31 August 2014

Mikael Ericson Will Be New CEO of Kemwell’s Swedish Operations

Kemwell has announced the appointment of Mikael Ericson as the new CEO of their Swedish operations.

Mr Ericson, highly experienced in production, logistics and lean management, assumed responsibilities on 1 September, and will succeed Agneta Bergvall.

He has held various international management positions in large corporations in pharmaceutical and automotive industries, including AstraZeneca, Scania and Plastal Industri.

Mr Ericson achieved great productivity improvements every year, by introducing new ways of working and engaging people in process development, without losing focus on the customer.

Chairman of the board PerÅke Oldentoft said: "With his in-depth technical and business background, Mikael will be an excellent leader for taking the company to the next level together along with Kemwell’s experienced associates."

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena